Efficacy of Platelet Rich Plasma Injection in Diabetic Neuropathy

Status Completed

Clinical Trial Summary

To evaluate the clinical efficacy and safety of peri-neural platelet rich plasma (PRP) injection in the treatment of diabetic peripheral neuropathy compared to traditional medical treatment.

Clinical Trial Description

Background: Neuropathy is a common complication of diabetes mellitus (DM) with a wide clinical spectrum that encompasses generalized to focal and multifocal forms not only leads to an impaired quality of life, but also to an increased morbidity and mortality . Till now there is no available effective therapy for the treatment of diabetic peripheral neuropathy (DPN). Autologous platelet-rich plasma is easy and cost-effective method as it provides necessary growth factors that promote wound healing/growth, angiogenesis, and axon regeneration .

Objective: To evaluate the clinical efficacy and safety of peri-neural platelet rich plasma (PRP) injection in the treatment of diabetic peripheral neuropathy compared to traditional medical treatment.

Method : Prospective double blinded randomized controlled trial was conducted . All included patients had type 2 DM selected from Endocrinology unit Department of Internal medicine, Assuit university Hospital, Egypt . DPN of at least 5 years duration of symptoms . Patients with other causes of neuropathy like hereditary neuropathies , entrapment neuropathies ,connective tissue diseases , vertebral diseases ,thyroid disorders and end organ failure were excluded . Neuropathy was assessed by the modified Toronto Clinical Neuropathy Score (mTCNS) 2001 (3) , Baseline pain and nerve conduction studies were done. Then they were double blindly divided into two groups, Group I underwent PRP preineural injection under ultrasound guidance plus medical treatment . Group װreceived medical treatment only( control group) . Blood glucose was strictly controlled in both groups . Patients were followed every month for 3 months by mTCNS and by nerve conduction studies. Results were expressed as means ± standard deviation or frequencies. Independent Student's t test was done for comparison between groups ;

Study Design

Related Conditions & MeSH terms

Diabetic Neuropathies
Diabetic Peripheral Neuropathy
Peripheral Nervous System Diseases

Clinical Trial Details

NCT number	NCT03250403
Study type	Interventional
Source	Assiut University
Contact
Status	Completed
Phase	N/A
Start date	April 1, 2017
Completion date	October 1, 2017

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04638556` - Effect of Circulating lncRNAs on Type 2 Diabetic Peripheral Neuropathy
Completed	`NCT05580705` - Effects of Vibration Therapy in Addition to Routine Physical Therapy in Patients With Diabetic Neuropathy	N/A
Terminated	`NCT01620775` - MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain	N/A
Completed	`NCT02127762` - The Effect of Mindfulness Based Stress Reduction in Patients With Painful Diabetic Peripheral Neuropathy	N/A
Completed	`NCT00835757` - Diffusion Tensor Imaging of Sural Nerves in Diabetic Peripheral Neuropathy	N/A
Recruiting	`NCT00553592` - Double Blind RCT of Bicifadine SR in Outpatients With Chronic Neuropathic Pain Associated With Diabetes	Phase 2
Recruiting	`NCT05863793` - Clinical Study of Acupuncture in the Treatment of Diabetic Peripheral Neuropathy	N/A
Withdrawn	`NCT05041816` - Peripheral Nerve Responses to Focal Vibration and Implications in Pain and Mobility for Patients With Diabetic Peripheral Neuropathy	N/A
Recruiting	`NCT06074562` - A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain	Phase 2
Recruiting	`NCT04457531` - LiuWeiLuoBi Granule for the Treatment of Diabetic Peripheral Neuropathy	Early Phase 1
Completed	`NCT02947828` - Polyneuropathy in Diabetes Mellitus Type 2
Completed	`NCT02056431` - Balancing Treatment Outcomes and Medication Burden Among Patients With Symptomatic Diabetic Peripheral Neuropathy	N/A
Completed	`NCT01681290` - Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes	Phase 2
Completed	`NCT01474772` - Efficacy and Safety Study of Pregabalin in the Treatment of Pain on Walking in Patients With Diabetic Peripheral Neuropathy (DPN)	Phase 3
Completed	`NCT01086150` - Use of Topical Lidocaine to Reduce Pain in Patients With Diabetic Neuropathy	Phase 2/Phase 3
Completed	`NCT03447756` - Titration Study of ABX-1431	Phase 1
Completed	`NCT04688671` - Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain	Phase 2
Completed	`NCT04984044` - Effect of Vitamin D in Patients With Diabetic Peripheral Neuropathy to Alleviate Pain and Improvement of Symptoms	N/A
Completed	`NCT06130917` - Effects of Multisystem Exercise on Balance, Postural Stability, Mobility and Pain in Patients With DPN.	N/A
Completed	`NCT01496365` - Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.